Now Available! | Check out UMR’s 2024 Annual Economic Report and State Toolkits today
NIH Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Rural State Analysis | UMR's 2023 Report Reveals the Exponential Impact of NIH Research Funding in 7 Rural States
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Washington University’s ‘underdog’ vaccine shows promise

A St. Louis startup has licensed a COVID-19 vaccine developed at Washington University that won’t be one of the first on the market, but could have advantages over other early vaccine contenders. An article in Nature this month described the Washington U. research as one of several “underdog” vaccines that could be important if early candidates fail, or confer only partial protection against COVID-19.